These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8140129)

  • 21. Pharmacokinetics of the gastrokinetic agent mosapride citrate after intravenous and oral administrations in rats.
    Sakashita M; Mizuki Y; Hashizume T; Yamaguchi T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Aug; 43(8):859-63. PubMed ID: 8216443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The disposition of prasugrel, a novel thienopyridine, in humans.
    Farid NA; Smith RL; Gillespie TA; Rash TJ; Blair PE; Kurihara A; Goldberg MJ
    Drug Metab Dispos; 2007 Jul; 35(7):1096-104. PubMed ID: 17403916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Biotransformation and pharmacokinetics of AWD 26-06, 8-chloro- 5,10-dihydro-5-[bis(2-hydroxyethyl)aminoacetyl]-11H-dibenzo[b,c] [1,4]diazepin-11-one hydrochloride, in the rat].
    Klemm W; Morgenroth U; Zerjatke W; Joram U; Gedan A; Pfeifer S
    Pharmazie; 1990 Jul; 45(8):607-9. PubMed ID: 2080210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs.
    Huskey SE; Dean BJ; Doss GA; Wang Z; Hop CE; Anari R; Finke PE; Robichaud AJ; Zhang M; Wang B; Strauss JR; Cunningham PK; Feeney WP; Franklin RB; Baillie TA; Chiu SH
    Drug Metab Dispos; 2004 Feb; 32(2):246-58. PubMed ID: 14744948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absorption and enterohepatic circulation of baicalin in rats.
    Xing J; Chen X; Zhong D
    Life Sci; 2005 Nov; 78(2):140-6. PubMed ID: 16107266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population pharmacokinetics of aprepitant and dexamethasone in the prevention of chemotherapy-induced nausea and vomiting.
    Nakade S; Ohno T; Kitagawa J; Hashimoto Y; Katayama M; Awata H; Kodama Y; Miyata Y
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):75-83. PubMed ID: 18317761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of 9-nitro-20(S)-camptothecin in rats.
    Zhong DF; Li K; Xu JH; Du Y; Zhang YF
    Acta Pharmacol Sin; 2003 Mar; 24(3):256-62. PubMed ID: 12617776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Biotransformation and pharmacokinetics of AWD 26-06, 8-chloro-5,10-dihydro-5-[bis(2-hydroxyethyl)aminoacetyl]-11H-dibenzo[d, c][1,4]diazepin-11-one hydrochloride in the rat].
    Pfeifer S; Gedan A; Franke P; Klemm W; Morgenroth U
    Pharmazie; 1990 Jul; 45(8):603-7. PubMed ID: 2080209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High performance liquid chromatographic analysis and preclinical pharmacokinetics of the heteroarotinoid antitumor agent, SHetA2.
    Zhang Y; Hua Y; Benbrook DM; Covey JM; Dai G; Liu Z; Chan KK
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):561-9. PubMed ID: 16534614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of capillary high performance liquid chromatography with electrospray mass spectrometry for the analysis of small volume blood samples from serially bled mice to determine the pharmacokinetics of early discovery compounds.
    Fraser IJ; Dear GJ; Plumb R; L'Affineur M; Fraser D; Skippen AJ
    Rapid Commun Mass Spectrom; 1999; 13(23):2366-75. PubMed ID: 10567936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
    Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR
    Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacokinetics and metabolic disposition of exogenous phosphocreatine in rats].
    Zou LL; Li QS; Han GZ; Lü L; Xi H; Li JH
    Yao Xue Xue Bao; 2011 Jan; 46(1):75-80. PubMed ID: 21465812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disposition of abouthiouzine: a novel antihyperthyroid drug.
    Alkharfy KM; Khan RM; Al-Hadiya BM; Abou-Auda HS; Abou-Shaaban RR
    Biopharm Drug Dispos; 2007 Apr; 28(3):105-11. PubMed ID: 17230598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodynamic response and effects on myocardial energetics of 3-cyano-2-morpholino-5-(pyrid-4-yl)pyridine (AWD 122-14) in anesthetized minipigs.
    Rohde E; Wiesner B; Muschick P
    Pharmazie; 1993 Sep; 48(9):690-4. PubMed ID: 8234405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonlinear oral pharmacokinetics of the alpha-antagonist 4-amino-5-(4-fluorophenyl)-6,7-dimethoxy-2-[4-(morpholinocarbonyl)-perhydro-1,4-diazepin-1-yl]quinoline in humans: use of preclinical data to rationalize clinical observations.
    Harrison A; Betts A; Fenner K; Beaumont K; Edgington A; Roffey S; Davis J; Comby P; Morgan P
    Drug Metab Dispos; 2004 Feb; 32(2):197-204. PubMed ID: 14744941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 4th communication: metabolism in rats and dogs.
    Hirota T; Nakamura A; Sugihara K; Morino A
    Arzneimittelforschung; 1997 Feb; 47(2):175-81. PubMed ID: 9079237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of the gastrokinetic agent mosapride citrate after intravenous and oral administrations in dogs and monkeys.
    Sakashita M; Mizuki Y; Yamaguchi T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Aug; 43(8):864-6. PubMed ID: 8216444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxicokinetics and biotransformation of 3-(4-methylbenzylidene)camphor in rats after oral administration.
    Völkel W; Colnot T; Schauer UM; Broschard TH; Dekant W
    Toxicol Appl Pharmacol; 2006 Oct; 216(2):331-8. PubMed ID: 16806338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.